JAK/STAT1-interferon-ISGylation networks in breast cancer resistance to inhibitors of FOXM1 and CDK4/6
Yvonne Ziegler(University of Illinois Urbana-Champaign), Benita S. Katzenellenbogen(University of Illinois Urbana-Champaign)
Cited by 0
Related Papers
Integration of Breast Cancer Secretomes with Clinical Data Elucidates Potential Serum Markers for Disease Detection, Diagnosis, and Prognosis
|PLoS ONE|2016|52
Plasma Membrane Proteomics of Human Breast Cancer Cell Lines Identifies Potential Targets for Breast Cancer Diagnosis and Treatment
|PLoS ONE|2014|49